Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Net Cash Flow (2017 - 2025)

Sensus Healthcare has reported Net Cash Flow over the past 9 years, most recently at -$2.4 million for Q4 2025.

  • Quarterly results put Net Cash Flow at -$2.4 million for Q4 2025, down 372.11% from a year ago — trailing twelve months through Dec 2025 was $27000.0 (up 102.43% YoY), and the annual figure for FY2025 was $27000.0, up 102.47%.
  • Net Cash Flow for Q4 2025 was -$2.4 million at Sensus Healthcare, down from $2.3 million in the prior quarter.
  • Over the last five years, Net Cash Flow for SRTS hit a ceiling of $18.3 million in Q1 2022 and a floor of -$12.1 million in Q4 2022.
  • Median Net Cash Flow over the past 5 years was $793000.0 (2022), compared with a mean of $357950.0.
  • Peak annual rise in Net Cash Flow hit 1559.04% in 2022, while the deepest fall reached 544.07% in 2022.
  • Sensus Healthcare's Net Cash Flow stood at -$1.9 million in 2021, then tumbled by 544.07% to -$12.1 million in 2022, then soared by 122.07% to $2.7 million in 2023, then plummeted by 118.87% to -$502000.0 in 2024, then tumbled by 372.11% to -$2.4 million in 2025.
  • The last three reported values for Net Cash Flow were -$2.4 million (Q4 2025), $2.3 million (Q3 2025), and $3.1 million (Q2 2025) per Business Quant data.